Skip to content

Robust ML Approach for Screening MET Drug Candidates in Combination with Immune Checkpoint Inhibitors

Present study highlights the significance of dataset size in ICI microbiota models and presents a methodology to enhance the performances of a multi-cohort-based ML approach. Conditioned to the performances we obtained, the healthy-pooled-donors-derived DS harbor a considerable ratio (91%) of ‘ICI Responder-like’, significantly higher than the mono-donor stools (73%) suggesting that pooled ecosystems from healthy donors could better convert ICI-non responders into responders.

Emmanuel Prestat, Elsa Schalck, Antoine Bonnefoy, Antoine Sabourin, Cyrielle Gasc, Carole Schwintner and Nathalie Corvaia, Robust machine learning approach for screening microbiome ecosystem therapies (MET) drug candidates in combination with immune checkpoint inhibitorsJournal for ImmunoTherapy of Cancer 2023;11:doi: 10.1136/jitc-2023-SITC2023.1304

 Click here to access the paper.
 

Releated Posts

Development & Evaluation of Automated Tumour Monitoring by Image Registration Based on 3D (PET/CT) Images

Tumor tracking in PET/CT is essential for monitoring cancer progression and guiding treatment strategies. Traditionally, nuclear physicians manually track tumors, focusing on the five largest ones (PERCIST criteria), which is both time-consuming and imprecise. Automated tumor tracking can allow matching of the numerous metastatic lesions across scans, enhancing tumor change monitoring.
Read More

Insights from Data & AI Tech Summit Warsaw 2025

11 editions later, one of the biggest technological conferences in Central Europe changed its name to reflect the latest technological advancements. The BIG DATA TECHNOLOGY WARSAW SUMMIT became the DATA & AI WARSAW TECH SUMMIT, and the conference provided a rich platform for gaining fresh perspectives on data and AI. Our CTO, Sabri Skhiri, was present to gather the insights. Here’s a rundown of the key trends, keynotes and talks that took place.
Read More